DOD Biotech (Thailand) Today
| DOD Stock | 2.08 0.02 0.95% |
Performance2 of 100
| Odds Of DistressLess than 9
|
DOD Biotech is selling for 2.08 as of the 3rd of December 2024. This is a 0.95 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 2.08. DOD Biotech has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for DOD Biotech Public are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Moving against DOD Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DOD Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DOD Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DOD Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Packaged Foods, Consumer Defensive, Computing (View all Sectors) |
DOD Biotech Public (DOD) is traded on Thailand Exchange in Thailand and employs 6 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DOD Biotech's market, we take the total number of its shares issued and multiply it by DOD Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DOD Biotech Public operates under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 410 M outstanding shares.
DOD Biotech generates positive cash flow from operations, but has no cash available
Check DOD Biotech Probability Of Bankruptcy
Ownership AllocationDOD Biotech holds a total of 410 Million outstanding shares. DOD Biotech Public retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check DOD Ownership Details
DOD Biotech Public Risk Profiles
Although DOD Biotech's alpha and beta are two of the key measurements used to evaluate DOD Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.32 | |||
| Semi Deviation | 2.18 | |||
| Standard Deviation | 4.1 | |||
| Variance | 16.8 |
DOD Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DOD Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
DOD Biotech Corporate Management
Elected by the shareholders, the DOD Biotech's board of directors comprises two types of representatives: DOD Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DOD. The board's role is to monitor DOD Biotech's management team and ensure that shareholders' interests are well served. DOD Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DOD Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dusit Chongsutthanamanee | Independent Sec | Profile | |
| Thanin Srisethi | Director CEO | Profile | |
| Suwarin Konthong | Chief CFO | Profile | |
| Nattawat Phetthai | Accounting Accountant | Profile | |
| Torlarp Chaiyachow | Acting Chairman | Profile | |
| Aekphusit Boonsiriyotthakul | COO Director | Profile |
Other Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.